FINWIRES · TerminalLIVE
FINWIRES

Wendy's US Comps Remain Weak With Little Improvement Seen, Morgan Stanley Says

By

Wendy's (WEN) US same-store-sales growth remained weak in June, with trends likely to continue in July and management not expecting any improvement in H2, Morgan Stanley said in a note Friday.

The investment firm said the management "reasonably" withdrew full-year guidance and new Chief Executive Bob Wright has identified the issues plaguing the company, including quality, value, operations and marketing, validating some of Morgan Stanley's prior cautious views.

Addressing these issues could be a meaningful mover for the stock, according to the note. The five key areas targeted under a turnaround plan include improving food quality while providing value, revamping branding and marketing, enhancing operations for customer satisfaction, improving digital tools, and aiming for unit growth and domestic expansion.

For the rest of the year, US same-store-sales growth is expected to be similar to H1, though this may be conservative, particularly in Q4, Morgan Stanley said. Wendy's also lowered its dividend to $0.07 for greater capital allocation flexibility, the firm added.

Morgan Stanley kept an underweight rating on Wendy's and lowered its price target to $5.50 from $7.

Shares of Wendy's were down 5% in Monday trading.

Price: $7.31, Change: $-0.39, Percent Change: -5.01%

Related Articles

Wire

GRAIL's Galleri Blood Test to Be Evaluated by US FDA Advisory Panel

GRAIL (GRAL) said Friday that an advisory panel of the US Food and Drug Administration will convene on Sept. 23 to evaluate the premarket approval application for its Galleri multi-cancer early detection blood test.The firm submitted the marketing application Jan. 29, incorporating trial results from 25,490 participants in its PATHFINDER 2 study along with over 70,000 subjects from its NHS-Galleri trial, the company said.Shares of the company were up about 8.9% in Friday trading.Price: $69.03, Change: $+5.63, Percent Change: +8.88%

$GRAL
Wire

Top Cryptocurrencies Rise; Bitcoin Holds Above $64,000

Major digital assets rose Friday with Bitcoin (BTC-USD) still holding above $64,000.The CoinDesk Market Index, which tracks dozens of digital assets including Bitcoin, rose 0.3% in the past 24 hours. The Nasdaq 100 added 1.3%, the S&P 500 gained 0.6%, and the Dow Jones Industrial Average increased 0.2%.Bitcoin gained 0.9% to $64,938, according to CoinMarketCap data. The most popular cryptocurrency's 24-hour trading volume rose almost 11% to $21.65 billion.Ethereum (ETH-USD), the second-largest digital asset by market value, rose 0.6% to $1,918.XRP (XRP-USD) fell 1.1%, BNB (BNB-USD) increased 0.5%, and Solana (SOL-USD) rose 1.5%. Dogecoin (DOGE-USD) added 1.6%, while Cardano (ADA-USD) dropped 0.8%.The total market value of the cryptocurrency industry rose 0.6% in the past 24 hours to $2.21 trillion, with trading volume rising 5.3% to $55.6 billion.Price: $64913.74, Change: $+654.06, Percent Change: +1.02%

$ADA-USD$BNB-USD$BTC-USD$DOGE-USD$ETH-USD$SOL-USD$XRP-USD
Wire

Celestica Completes $3.45 Billion Equity Offering

Celestica (CLS) said Friday it completed a $3.45 billion equity offering through the sale of about 11.1 million common shares priced at $310 each.The offering comprised roughly 9.7 million common shares, with the underwriters fully exercising their option to purchase an additional 1.5 million shares.Celestica said it expects to use the net proceeds for working capital, investments in capital expenditures and other general corporate purposes.Price: $317.60, Change: $+3.07, Percent Change: +0.98%

$CLS
Wendy's US Comps Remain Weak With Little Improvement Seen, Morgan Stanley Says | FINWIRES